Penn Researchers Prove Smoking Increases Risk Of Brain Complication

July 18, 1997


The whole thing is driving Dr. Lasner "nuts" because many of his friends are heavy smokers. Todd Lasner, a young neurosurgical resident, hopes those friends will stop smoking once they hear about the findings unearthed by a research team at the University of Pennsylvania Medical Center. There, Lasner and his colleagues demonstrated, for the first time, a scientific link between smoking cigarettes and cerebral blood-vessel damage. In a report to be published in the Journal of Neurosurgery [September 1997], the scientists have shown that smoking increases one's risk of cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH).

"This study is another piece of evidence to support how bad cigarette smoking is on the integrity of blood vessels," says Eugene Flamm, MD, Penn's Chairman of the Department of Neurosurgery and principal investigator of the study, "and it confirms the general impression of a lot of neurosurgeons that patients who smoke have a much more difficult time recovering from a brain hemorrhage than their non-smoking counterparts."

Vasospasm is a violent constriction of arterial walls that interferes with proper blood flow. Following surgery to correct a brain aneurysm, vasospasm occurs when blood spews into the subarachnoid region of the brain. (Such a hemorrhage is an expected complication from aneurysm surgery.) Depending on the intensity and duration of the vasospasm, patients may develop stroke-like symptoms -- including impaired speech, facial movement, and bodily sensations -- that result from the insufficient transport of oxygen to affected brain cells. Indeed, vasospasm is the major cause of delayed death in patients with disrupted aneurysms, and occurs in approximately one-third of all patients who get aneurysms.

For the study, Lasner examined the demographic features and clinical parameters (including smoking, high blood pressure, incidence of heart disease and diabetes) of 70 patients with aneurysmal SAH. They calculated that smokers have nearly five times the chance of developing vasospasm than non-smokers -- all other factors being equal.

The biochemical basis for the increased risk found in the study is unclear. It has been theorized, however, that smoking causes a rise in the serum level of endothelin -- a powerful vasoconstrictor that may mediate vasospasm. Cigarette smoking also seems to induce the impairment of blood vessels by increasing the adherence of plaque-causing molecules onto arterial walls.

"While the exact nature of smoking-induced biochemical deterioration remains cloudy, one message from this study is quite clear -- smoking is hazardous to your health!" says Dr. Lasner. "And, even if I can't convince my friends to quit, I hope the results of our study may prevent others from starting to smoke or convince them to stop."
-end-


University of Pennsylvania School of Medicine

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.